Taking statins protects people against heart disease and stroke. This has prompted physicians to prescribe statins to people at high risk of these conditions. The researchers found that "over the two and a half year period of the study, the proportion of patients taking statins when they were admitted to hospital increased," from 16% of stroke patients in 2000 to 26% of stroke patients in 2002.
This new research showed that patients who have been taking statins prior to their stroke have a better outcome. The authors concluded: "This finding could support the early initiation of statin therapy after stroke," though they propose that further studies should be undertaken to test this hypothesis.
The researchers observed 433 patients who were admitted to the NINDS Stroke Program at Suburban Hospital in Bethesda, Maryland suffering from ischemic stroke.
51% of the patients who were taking statins on admission left hospital with no significant disability (i.e. they were functionally independent). This compares with 38% of patients who were not taking statins when they were admitted to hospital.
Although prior statin use was associated with improved outcome after stroke, this research did not show that it reduced the severity of the stroke. There were no significant differences in the severity of strokes suffered by patients who had been taking statins, and those who had not.
This press release is based on the following article:
Rising statin use and effect on ischemic stroke outcome
Sung Sug Yoon, James Dambrosia, Julio Chalela, Mustapha Ezzeddine, Steven Warach, Joseph Haymore, Lisa Davis, Alison E Baird
BMC Medicine 2004, 2:4
To be published Tuesday 23 March, 2004
Upon publication this article will be available free of charge as per BMC Medicine's Open Access policy at: http://www.biomedcentral.com/1741-7015/2/4/abstract
For further information about this research, please contact Alison E. Baird by email at bairda@ninds.nih.gov or by phone on 301-402-1039.
Alternatively, or for further information about the journal or Open Access publishing, please contact Gemma Bradley by email at press@biomedcentral.com or by phone on 44-207-323-0323.
BMC Medicine (http://www.biomedcentral.com/bmcmed/) publishes original research articles, technical advances and study protocols in any area of medical science or clinical practice. To be appropriate for BMC Medicine, articles need to be of special importance and broad interest.
BMC Medicine is published by BioMed Central (http://www.biomedcentral.com), an independent online publishing house committed to providing Open Access to peer-reviewed biological and medical research. This commitment is based on the view that immediate free access to research and the ability to freely archive and reuse published information is essential to the rapid and efficient communication of science. BioMed Central currently publishes over 100 journals across biology and medicine. In addition to open-access original research, BioMed Central also publishes reviews, commentaries and other non-original-research content. Depending on the policies of the individual journal, this content may be open access or provided only to subscribers.
Journal
BMC Medicine